Riju Ray

<p>Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study</p>

Chad Moretz, Lucie Sharpsten, Lindsay G.S. Bengtson et al. · International Journal of COPD · 2019 · 21 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA

Beth Hahn, Michael Hüll, Cori Blauer‐Peterson et al. · Respiratory Medicine · 2018 · 19 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

<p>Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol</p>

Chad Moretz, Lindsay G.S. Bengtson, Lucie Sharpsten et al. · International Journal of COPD · 2019 · 17 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials

Riju Ray, Lee Tombs, Ian Naya et al. · Pulmonary Pharmacology & Therapeutics · 2019 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting

Suzanne G. Bollmeier, Terry Seaton, Theresa R. Prosser et al. · Journal of the American Pharmacists Association · 2019 · 15 citations · Full text

Pharmacy, Community Pharmacy, Pharmacy Practice +17